Common use of Termination if Genmab Challenges SGI Patents Clause in Contracts

Termination if Genmab Challenges SGI Patents. SGI may terminate this Agreement for cause at any time after thirty (30) days written notice to Genmab of its intent to so terminate if Genmab, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any SGI Patent. Any such termination shall not become effective if Genmab has withdrawn such action before the end of the above notice period, provided such withdrawal effectively terminates the action and has not materially adversely affected any of SGI’s rights under the Agreement.

Termination if Genmab Challenges SGI Patents. SGI may terminate this Agreement for cause at any time after thirty (30) days [ * ] written notice to Genmab of its intent to so terminate if Genmab, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any SGI Patent. Any such termination shall not become effective if Genmab has withdrawn such action before the end of the above notice period[ * ], provided such withdrawal effectively terminates the action and has not materially adversely affected any of SGI’s rights under the Agreement.[ * ]. 17.5

Termination if Genmab Challenges SGI Patents. SGI may terminate this Agreement for cause at any time after thirty (30) days [ * ] written notice to Genmab of its intent to so terminate if Genmab, its Affiliates or Sublicensees, challenges the validity, enforceability, patentability or scope of a claim of any SGI Patent. Any such termination shall not become effective if Genmab has withdrawn such action before the end of the above notice period[ * ], provided such withdrawal effectively terminates the action and has not materially adversely affected any of SGI’s rights under the Agreement[ * ].